Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Food And Drug Administration

Food and Drug Administration

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments.

Read More at Wikipedia
US HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Friday's session are Delphi Automotive PLC (DLPH), VeriFone Systems Inc.

(PAY) and SemTech Corp. (SMTC).Delphi made a binding offer to acquire FCI Group's motorized vehicles division in a deal valued at EUR765 million, or $972 million, that will strengthen the parts maker's connector product portfolio. The deal is expected to be accretive to the company's 2013 earnings. Shares jumped 12% to $30.91 after hours.VeriFone's fiscal second-quarter earnings fell 43% as restructuring and acquisition-related costs continued to overshadow stronger revenue and better-than-expected core profit. Shares sank 9.4% to $40.77 after hours as guidance estimates were mostly below Wall Street expectations.Semtech's first-quarter earnings slid 90% as expenses and a purchase accounting adjustment related to the chip maker's acquisition of Gennum Corp. weighed on margins and bottom-line results. Shares slipped 4% to $22.75 after hours as adjusted e...

Read More

  1. J&J's Simponi Helps Colitis Patients In Clinical Trial

    Johnson & Johnson (JNJ) said its drug Simponi improved symptoms in a majority of patients with an inflammatory-bowel disease in a new clinical trial.The results, rel...

  2. FDA Reviewer Backs Expanded Approval Of Bayer, J&J's Xarelto

    A Food and Drug Administration medical reviewer recommended the agency expand the approval of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting ...

  3. FDA Reviewer Recommends Expanded Approval Of Bayer, J&J's Xarelto

    A Food and Drug Administration medical reviewer recommended the agency expand the approval of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting ...

  4. Regulators Recommend Approval of Over-the-Counter HIV Test

    Orasure Technologies CEO Douglas Michels on efforts to get FDA approval of the first over-the-counter HIV test and make it available to consumers by the summer.

  5. WSJ BLOG/Health: A.M. Vitals: New Alzheimer's Trial; Home HIV Test

    Here's what's making health news this morning:New Bid to Prevent Alzheimer's Early (WSJ): An Alzheimer's drug to be tested mostly on an extended family predisposed t...

  6. WSJ BLOG/Health: New Caution Urged Over Sole Oral MS Drug On the Market

    The FDA says the only oral multiple-sclerosis drug on the market -- Novartis's Gilenya -- shouldn't be used in patients with a recent history of stroke or some heart...

  7. FDA Concludes Safety Review Of Novartis MS Drug Gilenya

    The U.S. Food and Drug Administration Monday said Novartis AG's (NVS, NOVN.VX) multiple-sclerosis drug Gilenya shouldn't be used in patients with a recent history of...

  8. Nestle Voluntarily Recalls Canned Cat Food On Low Thiamine Levels

    Nestle SA (NESN.VX) is voluntarily recalling one lot of canned cat food after a product sample by the U.S. Food and Drug Administration indicated a low level of thia...

  9. Producer Prices Unexpectedly Drop in April

    FBN’s Robert Gray on the 0.2% drop in producer prices in April.

  10. Arena News Boosts Orexigen, Vivus Shares

    Shares of diet-drug developer Orexigen Therapeutics shot up 20% to $4.03 Friday in the wake of news that an advisory panel of the U.S. Food and Drug Administration h...

  11. FDA Panel Backs Gilead's HIV 'Quad' Medicine

    A federal advisory panel Friday backed an experimental Gilead Sciences Inc. (GILD) HIV medicine known as the Quad.The company is seeking approval from the Food and D...

  12. May Consumer Sentiment Hits More Than 4-Year High

    FBN's Tracy Byrnes breaks down afternoon market news.

  1. FDA Panel: Data Could Support Approval Of Pfizer Drug Tafamidis

    A Food and Drug Administration advisory panel said a clinical study submitted by Pfizer Inc. (PFE) for a drug to treat a rare genetic disorder that affects the nervo...

  2. Bayer Backs Xarelto Sales Forecast After FDA Panel Votes Against Expanded Use

    German pharmaceutical company Bayer AG (BAYN.XE) Thursday confirmed it sees peak annual sales of its Xarelto drug above EUR2 billion after a U.S. Food and Drug Admin...

  3. FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelto

    A Food and Drug Administration advisory panel narrowly voted against expanded use of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting drug Xare...

  4. Bayer Submits Regorafenib For EU, US. Marketing Authorization

    German pharmaceutical company Bayer AG's (BAYN.XE) HealthCare unit Wednesday said it applied for marketing authorization in the E.U. and the U.S. for its oral drug R...

  5. FDA Reviewer Recommends Against Approval Of Pfizer Drug

    A Food and Drug Administration medical reviewer recommended the agency not approve a drug developed by a Pfizer Inc. (PFE) subsidiary to treat a rare genetic disorde...

  6. Beware of Phony Pharmaceuticals

    Author Roger Bate on the growing dangers associated with imported ingredients in pharmaceuticals.

  7. Chinese Company Buys AMC for $2.6B

    University of Maryland Economist Peter Morici on the potential risks from Chinese acquisitions of U.S. companies.

‹ Prev12345Next ›
Freebase CC-BY
Source: Food And Drug Administration on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL